BioAtla Inc. (NASDAQ: BCAB) stock closed at 1.79 per share at the end of the most recent trading day (a -9.14% change compared to the prior day closing price) with a volume of 370.29K shares and market capitalization of 85.57M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 36 people. BioAtla Inc. CEO is Jay M. Short.

The one-year performance of BioAtla Inc. stock is -76.82%, while year-to-date (YTD) performance is -78.3%. BCAB stock has a five-year performance of %. Its 52-week range is between 1.93 and 11.73, which gives BCAB stock a 52-week price range ratio of -1.43%

BioAtla Inc. currently has a PE ratio of -3.00, a price-to-book (PB) ratio of 2.17, a price-to-sale (PS) ratio of 439.68, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -43.85%, a ROC of -53.94% and a ROE of -54.83%. The company’s profit margin is -%, its EBITDA margin is -39 848.00%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from BioAtla Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.77 for the next earnings report. BioAtla Inc.’s next earnings report date is 03rd Nov 2023.

The consensus rating of Wall Street analysts for BioAtla Inc. is Strong Buy (1), with a target price of $23.83, which is +1 231.28% compared to the current price. The earnings rating for BioAtla Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioAtla Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioAtla Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 41.70, ATR14 : 0.15, CCI20 : -128.14, Chaikin Money Flow : -0.32, MACD : -0.20, Money Flow Index : 12.85, ROC : -31.42, RSI : 26.35, STOCH (14,3) : 1.10, STOCH RSI : 0.00, UO : 26.74, Williams %R : -98.90), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioAtla Inc. in the last 12-months were: Christian Vasquez (Buy at a value of $47 970), Jay M. Short (Buy at a value of $100 862), Jay Short (Buy at a value of $100 776), Sylvia McBrinn (Buy at a value of $52 433), Vasquez Christian (Buy at a value of $48 000)